Decade-Long heart valve watch begins in europe
NCT ID NCT06953206
Summary
This study will follow 500 patients in Europe for 10 years after they receive a specific type of replacement heart valve called the SAPIEN 3 Ultra RESILIA. The goal is to see how well the valve works and holds up over a long period, especially as more younger patients receive these valves and need them to last. Researchers will track valve performance, safety, and patient health outcomes over the full decade.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AORTIC STENOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Heart and Diabetes Center North Rhine-Westphalia
Bad Oeynhausen, North Rhine-Westphalia, 32545, Germany
Conditions
Explore the condition pages connected to this study.